Merck Price Negotiation Lawsuit May Face Same Obstacles as 340B Takings Claims
Past 340B litigation highlights that takings challenges to the Medicare price negotiation program face an uphill battle.

Past 340B litigation highlights that takings challenges to the Medicare price negotiation program face an uphill battle.
In January, the FTC released a draft rule that would ban non-compete clauses. This may promote competition and innovation in biotechnology.
Amazon’s health care strategy points to the profound implications of a broader integrated consumer-centric model.
Now is a pivotal time for the American Medical Association to reconsider its aggressive scope of practice lobbying.
Today’s pandemic destabilized hospital care because hospitals were neither coordinated nor managed systemically in order to meet population demands.
Most seniors and their loved ones don’t realize the barriers that make aging in place a difficult proposition until a crisis occurs.
Clinicians across medical settings commonly euphemize or understate pain, which has concerning implications for patient trust, consent, and care quality.